Impact of metabolic dysfunction-associated steatotic liver disease on liver metastasis and survival in pancreatic cancer

doi:10.3748/wjg.v32.i11.115488

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 32, Issue 11

This Article

Peer-Review Report of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Supplementary Materials of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (233)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-1) series, Tables (1-5) series.

Item

Count

PDF

HTML

Figures (1-1)

Tables (1-5)

Sum=128

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

Download

Sum=80

Mar 21, 2026 (publication date) through Apr 5, 2026

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Cohort Study

Copyright: ©Author(s) 2026. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution-NonCommercial (CC BY-NC 4.0) license. No commercial re-use. See permissions. Published by Baishideng Publishing Group Inc.

World J Gastroenterol. Mar 21, 2026; 32(11): 115488
Published online Mar 21, 2026. doi: 10.3748/wjg.v32.i11.115488

Open in New Tab Full Size Figure Download Figure

Figure 1 Cumulative incidence of liver metastasis stratified in patients without liver metastasis at baseline. A: Hepatic steatosis index 30 group; B: Hepatic steatosis index 36 group. HSI: Hepatic steatosis index.

Citation: Chon HY, Rhee H, Kim J, Leem G, Jo JH, Chung MJ, Park JY, Bang S, Park SW, Kim SU, Lee HS. Impact of metabolic dysfunction-associated steatotic liver disease on liver metastasis and survival in pancreatic cancer. World J Gastroenterol 2026; 32(11): 115488
URL: https://www.wjgnet.com/1007-9327/full/v32/i11/115488.htm
DOI: https://dx.doi.org/10.3748/wjg.v32.i11.115488